SD Biosensor, Inc. (KRX:137310)

Market Cap	986.91B -9.3%
Revenue (ttm)	718.78B +2.2%
Net Income	-470.73B
EPS	-3,935.13
Shares Out	118.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (2.40%)
Ex-Dividend Date	Mar 30, 2026

Volume	156,387
Average Volume	149,595
Open	8,050.00
Previous Close	7,960.00
Day's Range	8,030.00 - 8,350.00
52-Week Range	7,100.00 - 13,550.00
Beta	0.75
RSI	53.01
Earnings Date	May 15, 2026

About SD Biosensor

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides ST...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2025, SD Biosensor's revenue was 710.58 billion, an increase of 2.30% compared to the previous year's 694.57 billion. Losses were -512.11 billion, 420.4% more than in 2024.